Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Can-Fite BioPharma
Biotech
BMS CEO set to leave after 8-year run—Chutes & Ladders
BMS CEO retiring. AbbVie plots CEO succession. Ipsen taps new CMO.
Max Bayer
,
Gabrielle Masson
Apr 28, 2023 9:30am
Can-Fite digs into subpopulation data on liver cancer drug
Mar 26, 2019 10:34am
Can-Fite liver cancer trial is delayed—is it good news?
Jun 19, 2018 9:18am